IS THERE A SURVIVAL BENEFIT FOR PATIENTS WHO RECEIVE POST-OPERATIVE ADJUVANT CHEMOTHERAPY FOLLOWING SECONDARY CYTOREDUCTIVE SURGERY (SCRS) FOR RECURRENT EPITHELIAL OVARIAN CANCER (EOC)?

被引：0
|
作者：
Kolomainen, D. F. [1 ]
Butler, J. [1 ]
Barton, D. P. J. [1 ]
Ind, T. E. J. [1 ]
Nobbenhuis, M. A. E. [1 ]
Lalondrelle, S. [1 ]
Taylor, A. [1 ]
Shepherd, J. H. [1 ]
Gore, M. E. [1 ]
Kaye, S. B. [1 ]
Banerjee, S. [1 ]
机构：
[1] Royal Marsden Hosp, Gynaecol Canc Unit, London SW3 6JJ, England
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0631
引用
收藏
页码：1407 / 1407
页数：1
相关论文
共 50 条
  • [1] Is there a survival benefit for patients who receive post-operative adjuvant chemotherapy following secondary cytoreductive surgery (SCRS) for recurrent epithelial ovarian cancer (EOC)?
    Kolomainen, D.
    Butler, J.
    Barton, D. P. J.
    Taylor, A.
    Stanley, K.
    Gore, M.
    Banerjee, S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S550 - S550
  • [2] POST-OPERATIVE ADJUVANT RADIOTHERAPY FOLLOWING SECONDARY CYTOREDUCTIVE SURGERY (SCRS) FOR RECURRENT EPITHELIAL OVARIAN CANCER (EOC)
    Kolomainen, D.
    Butler, J.
    Barton, D.
    Taylor, A.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 743 - 743
  • [3] SECONDARY CYTOREDUCTIVE SURGERY (SCRS) FOR RECURRENT EPITHELIAL OVARIAN CANCER (EOC): AN ANALYSIS OF PATIENTS TREATED AT BRAZILIAN NATIONAL CANCER INSTITUTE (INCA)
    Melo, A. C.
    Dias, M. F.
    Garces, A. H. I.
    Renna, N.
    Bizzo, S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 190 - 190
  • [4] Secondary cytoreductive surgery for recurrent ovarian cancer: who will get the most benefit?
    Son, Joo-Hyuk
    Yum, Sun Hyung
    Kong, Tae-Wook
    Paek, Jiheum
    Chang, Suk-Joon
    Ryu, Hee-Sug
    [J]. GYNECOLOGIC ONCOLOGY, 2021, 162 : S7 - S7
  • [5] Survival of patients with advanced ovarian cancer treated with intermittent chemotherapy following cytoreductive surgery and adjuvant chemotherapy
    Amikura T.
    Aoki Y.
    Kase H.
    Watanabe M.
    Sato T.
    Fujita K.
    Kurata H.
    Tanaka K.
    [J]. International Journal of Clinical Oncology, 2002, 7 (1) : 45 - 50
  • [6] Outcomes of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
    Gockley, A. A.
    Cronin, A.
    Bookman, M. A.
    Burger, R. A.
    Cristea, M.
    Griggs, J. J.
    Mantia-Smaldone, G. M.
    Meyer, L. A.
    O'Malley, D. M.
    Wright, A. A.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 81 - 82
  • [7] Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer
    Zang, RY
    Zhang, ZY
    Li, ZT
    Chen, J
    Tang, MQ
    Liu, Q
    Cai, SM
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2000, 75 (01) : 24 - 30
  • [8] Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
    Jeong, Soo Young
    Choi, Chel Hun
    Kim, Tae Joong
    Lee, Jeong Won
    Kim, Byoung-Gie
    Bae, Duk Soo
    Lee, Yoo-Young
    [J]. JOURNAL OF OVARIAN RESEARCH, 2019, 13 (01)
  • [9] Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
    Soo Young Jeong
    Chel Hun Choi
    Tae Joong Kim
    Jeong Won Lee
    Byoung-Gie Kim
    Duk Soo Bae
    Yoo-Young Lee
    [J]. Journal of Ovarian Research, 13
  • [10] Potential Survival Benefit of Secondary Cytoreductive Surgery for Recurrent Epithelial Ovarian, Tubal, and Peritoneal Cancers
    Goto, Tomoko
    Takano, Masashi
    Watanabe, Akio
    Miyamoto, Morikazu
    Kato, Masafumi
    Hirata, Junko
    Sasa, Hidenori
    Furuya, Kenichi
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (02) : 263 - 268
12345